African American exome sequencing identifies potential risk variants at Alzheimer disease loci. (April 2017)

• Record Type: Journal Article
• Authors: N'Songo, Aurelie; Carrasquillo, Minerva M.; Wang, Xue; Burgess, Jeremy D.; Nguyen, Thuy; Asmann, Yan W.; Serie, Daniel J.; Younkin, Steven G.; Allen, Mariet; Pedraza, Otto; Duara, Ranjan; Greig Custo, Maria T.; Graff-Radford, Neill R.; Ertekin-Taner, Nilüfer
• Is Part Of: Neurology. Volume 3:Number 2(2017)
• Publication Date: 2017-04
• Subjects: Neurogenetics -- Periodicals; 616.80442
• DOI: 10.1212/NXG.0000000000000141
• Languages: English
• ISSNs: 2376-7839

Abstract

Abstract : Objective: In African Americans, we sought to systematically identify coding Alzheimer disease (AD) risk variants at the previously reported AD genome-wide association study (GWAS) loci genes. Methods: We identified coding variants within genes at the 20 published AD GWAS loci by whole-exome sequencing of 238 African American participants, validated these in 300 additional participants, and tested their association with AD risk in the combined cohort of 538 and with memory endophenotypes in 319 participants. Results: Two ABCA7 missense variants (rs3764647 and rs3752239) demonstrated significant association with AD risk. Variants in MS4A6A, PTK2B, and ZCWPW1 showed significant gene-based association. In addition, coding variants in ZCWPW1 (rs6465770) and NME8 (rs10250905 and rs62001869) showed association with memory endophenotypes. Conclusions: Our findings support a role for ABCA7 missense variants in conferring AD risk in African Americans, highlight allelic heterogeneity at this locus, suggest the presence of AD-risk variants in MS4A6A, PTK2B, and ZCWPW1, nominate additional variants that may modulate cognition, and importantly provide a thorough screen of coding variants at AD GWAS loci that can guide future studies in this population.